Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0BZ7W
|
||||
Former ID |
DAP000376
|
||||
Drug Name |
Tolterodine
|
||||
Synonyms |
Tolterodina; Tolterodinum; Detrol (TN); Detrusitol (TN); Kabi-2234; 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol; 2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol; 2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol; 2-{(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl}-4-methylphenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Overactive bladder [ICD9: 596.51; ICD10:N32.81] | Approved | [551871] | ||
Therapeutic Class |
Antispasmodics
|
||||
Company |
Pfizer Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H31NO
|
||||
InChI |
InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1
|
||||
InChIKey |
OOGJQPCLVADCPB-HXUWFJFHSA-N
|
||||
CAS Number |
CAS 124937-51-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9952, 7847712, 14777260, 14801661, 23936567, 29215497, 36887062, 46508059, 48416646, 49666284, 50070814, 56322577, 56464111, 57404545, 75101389, 85083128, 89736135, 92712344, 93166476, 93618065, 103463555, 104050603, 104179074, 104630915, 118048147, 118048994, 124799394, 126625639, 126656774, 126668318, 127315558, 127315559, 127315560, 128837711, 135651269, 137028044, 140085486, 143493272, 144205290, 151981130, 152034997, 152236221, 164234496, 164765641, 164787750, 170465337, 172440007, 175265551, 176485082, 179116925
|
||||
ChEBI ID |
ChEBI:9622
|
||||
SuperDrug ATC ID |
G04BD07
|
||||
SuperDrug CAS ID |
cas=124937515
|
||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M3 | Target Info | Antagonist | [535660], [535903] | |
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.